Images

 

2009_World Markets Oncology.qxd
www.ihs.com
WORLD MARKETS ONCOLOGY How are pharmaceutical companies and regulatory bodies dealing with increasing costs of — and market access barriers to — new oncology drugs? What happens when new products, generics, and/or biosimilars change the competitive landscape? What is in pipeline development that

Results 1-1 of 1
 


Refine by Content Type:

  • Refined by: Images  


Refine by Source:

Choose a source :

Close

1 Sources ...